ArticleWorld journal of gastrointestinal surgery2025
Long-term survival after multimodality treatment of metastatic mixed adenoneuroendocrine carcinoma of colon: A case report.
Article in World journal of gastrointestinal surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMixed adenoneuroendocrine carcinoma (MANEC) is a rare malignancy that can be effectively treated with surgery in its early stages. However, there is currently no established treatment protocol for metastatic cases. CASE SUMMARY: We present a case of a patient diagnosed with liver metastasis (LM) from ascending colon MANEC. The patient is a 40-year-old male who was diagnosed to have ascending colon MANEC with LM in March 2014. Following surgical resection of both the primary tumor and the LM, the patient received first-line chemotherapy with the mFOLFOX6 regimen. After six months of the initial treatment, the patient experienced multiple recurrences of LM. These LM were successfully treated by a multidisciplinary approach including chemotherapy, surgical resection, and radiofrequency ablation (RFA). Remarkably, in June 2017, the patient achieved a complete response, which has been maintained to date, resulting in overall long-term survival of ten years. Advanced colorectal MANEC is often associated with LM, and multiple intrahepatic recurrences may be characteristic of this disease.
conclusionThe use of local treatment modalities, such as surgery and RFA, in conjunction with chemotherapy, has demonstrated promising efficacy and warrants further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.